305 related articles for article (PubMed ID: 35168419)
61. Imaging Characteristics of CNS Neuroblastoma-
Tietze A; Mankad K; Lequin MH; Ivarsson L; Mirsky D; Jaju A; Kool M; Hoff KV; Bison B; Löbel U
AJNR Am J Neuroradiol; 2022 Oct; 43(10):1476-1480. PubMed ID: 36137662
[TBL] [Abstract][Full Text] [Related]
62. Aggressive infantile embryonal tumors.
MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
[TBL] [Abstract][Full Text] [Related]
63. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion.
Andreiuolo F; Ferrone CK; Rajan S; Perry A; Guney E; Cham E; Giannini C; Toland A; Willard N; de Souza AS; Dazelle K; Chung HJ; Singh O; Conway K; Coley N; Dampier C; Abdullaev Z; Pratt D; Cimino PJ; Quezado M; Aldape K
Acta Neuropathol Commun; 2024 Mar; 12(1):42. PubMed ID: 38500181
[TBL] [Abstract][Full Text] [Related]
64. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
65. Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?
Mascarin M; Coassin E; Franceschi E; Gandola L; Carrabba G; Brandes AA; Massimino M
Childs Nerv Syst; 2019 Dec; 35(12):2279-2287. PubMed ID: 31414168
[TBL] [Abstract][Full Text] [Related]
66. Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology.
Alturkustani M; Walker AD; Tran I; Snuderl M; Cotter JA
Pathol Int; 2022 Aug; 72(8):402-410. PubMed ID: 35763016
[TBL] [Abstract][Full Text] [Related]
67. Newly defined central nervous system neoplasms.
Gyure KA
Am J Clin Pathol; 2005 Jun; 123 Suppl():S3-12. PubMed ID: 16100866
[TBL] [Abstract][Full Text] [Related]
68. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
Koral K; Gargan L; Bowers DC; Gimi B; Timmons CF; Weprin B; Rollins NK
AJR Am J Roentgenol; 2008 Mar; 190(3):809-14. PubMed ID: 18287456
[TBL] [Abstract][Full Text] [Related]
69. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
Chatterjee D; Gupta K
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
71. [Update on the 2016 WHO classification of tumors of the central nervous system.Part 2: Embryonal tumors and other tumor groups (except for diffuse gliomas)].
Zámečník J; Rychlý B; Švajdler M
Cesk Patol; 2017; 53(1):22-28. PubMed ID: 28248118
[TBL] [Abstract][Full Text] [Related]
72. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract][Full Text] [Related]
73. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
74. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
75. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
76. Atypical teratoid rhabdoid tumor mimicking beta-catenin-positive nodular medulloblastoma.
Varlet P; Beaugrand A; Lacroix L; Lequin D; Pierron G; Puget S; Negretti L; Boddaert N; Grill J; Dufour C
Acta Neuropathol; 2011 Mar; 121(3):429-30. PubMed ID: 21229255
[No Abstract] [Full Text] [Related]
77. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Miller DC
Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
[TBL] [Abstract][Full Text] [Related]
78. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Rodriguez A; Kamiya-Matsuoka C; Majd NK
Curr Oncol; 2023 May; 30(6):5279-5298. PubMed ID: 37366884
[TBL] [Abstract][Full Text] [Related]
79. Prediction of central nervous system embryonal tumour outcome based on gene expression.
Pomeroy SL; Tamayo P; Gaasenbeek M; Sturla LM; Angelo M; McLaughlin ME; Kim JY; Goumnerova LC; Black PM; Lau C; Allen JC; Zagzag D; Olson JM; Curran T; Wetmore C; Biegel JA; Poggio T; Mukherjee S; Rifkin R; Califano A; Stolovitzky G; Louis DN; Mesirov JP; Lander ES; Golub TR
Nature; 2002 Jan; 415(6870):436-42. PubMed ID: 11807556
[TBL] [Abstract][Full Text] [Related]
80. [Pediatric brain tumors].
Pietsch T
Pathologie (Heidelb); 2023 Nov; 44(6):373-380. PubMed ID: 37755475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
